Nalaganje...
Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis
BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...
Shranjeno v:
| izdano v: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/ https://ncbi.nlm.nih.gov/pubmed/29330211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|